Health ministry report bats for liver and heart transplants under PMJAY
New Delhi: The union health ministry has called for including liver and heart transplants under the government's flagship health insurance scheme, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY).
This assumes importance given that health insurance schemes in the country cover life and disability, but not organ donation.
Also Read | Why are men ignoring their hormonal health?
The recommendation comes in a report, titled the National Review Meeting on Organ Transplantation Activities in Government Hospitals, prepared by the National Organ Tissue Transplant Organization (NOTTO), a top body which manages organ transplantation, under the health ministry.
The call for expanding insurance coverage comes in the backdrop of the low number of organ transplants performed in India. Mint has seen a copy of the report, which has been submitted to health ministry.
Also Read | Want glowing skin? Take care of your mental health
AB PM-JAY is the world's largest health insurance scheme, providing health cover of ₹5 lakh per family per year. Notably, the scheme's ambit has been expanded to include free treatment benefits of up to ₹5 lakh per year to senior citizens aged 70 years and above.
Earlier this month, a nationwide review meeting was conducted on organ transplants in government hospitals by a group of top government experts to identify bottlenecks in the system and formulate a roadmap for improvement.
The report underlined that government institutions have inadequate capacities and that new centres are required to be established and made functional. It emphasized the need for a multi-pronged strategy involving policy changes, financial investment, and capacity building to bridge the demand-supply gap in organ transplantation.
Also Read | ₹1-crore health cover is fast becoming a necessity. But how to afford one?
The report highlighted a huge gap between demand and supply: while India requires at least 100,000 kidney transplants per year, only 13,476 were performed in 2024 across both government and private centers.
'These recommendations aim to strengthen India's organ transplantation capabilities and make life-saving procedures more accessible to those in need. During the nationwide assessment of the government hospitals, we identified their challenges and suggested measures to improve their capabilities in terms of infrastructure, finance, manpower etc. We have submitted our report to the health ministry and now the ministry will take action on these recommendations," said Dr. Anil Kumar, director, NOTTO.
One of the key recommendations is to include comprehensive inclusion of liver and heart transplantation in national health schemes like PMJAY, he added.
'Some states like Maharashtra and Delhi have expanded their coverage under the PM-JAY scheme. So, the recommendation of the report to include liver and heart transplantation under PM-JAY may be considered to accelerate organ transplantation in the government institutions," he said.
Dr Anup Kumar, head of kidney transplant and urology department at Safdarjung Hospital, New Delhi, said, ' It is a welcome move. PMJAY offers coverage of up to ₹5 lakh, but these are very expensive procedures require ₹20-25 lakh in the private sector. However, in government institutions these transplants can be done in ₹10 lakh. So, to cover these two transplants, the government has to also consider increasing the coverage plan of PMJAY from ₹5 lakh to at least ₹10 lakh."
Further, to bridge the critical demand-supply gap, the expert group has put forth several key recommendations, which include financial incentives for transplant teams, enhanced funding for infrastructure development, establishment of dedicated transplant centres and robust training programmes for medical personnel and transplant coordinators.
'We have tried to understand why government institutions are not able to do the maximum number of organ transplants and what are the solutions. Do we require to build new centres or strengthen the existing capacities. Some government centres like Institute of Kidney Diseases and Research Centre (IKDRC) Ahmedabad conducted a total of 508 organ transplants in the last year, including 195 cadaveric transplants, PGIMER Chandigarh performed 320 organ transplants including 55 cadaveric transplants," Dr. Kumar said.
However, the report revealed that government institutions like GB Pant Hospital, New Delhi, despite having the physical infrastructure and licence, did not perform any organ transplants.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
10 hours ago
- Mint
Health ministry report bats for liver and heart transplants under PMJAY
New Delhi: The union health ministry has called for including liver and heart transplants under the government's flagship health insurance scheme, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY). This assumes importance given that health insurance schemes in the country cover life and disability, but not organ donation. Also Read | Why are men ignoring their hormonal health? The recommendation comes in a report, titled the National Review Meeting on Organ Transplantation Activities in Government Hospitals, prepared by the National Organ Tissue Transplant Organization (NOTTO), a top body which manages organ transplantation, under the health ministry. The call for expanding insurance coverage comes in the backdrop of the low number of organ transplants performed in India. Mint has seen a copy of the report, which has been submitted to health ministry. Also Read | Want glowing skin? Take care of your mental health AB PM-JAY is the world's largest health insurance scheme, providing health cover of ₹5 lakh per family per year. Notably, the scheme's ambit has been expanded to include free treatment benefits of up to ₹5 lakh per year to senior citizens aged 70 years and above. Earlier this month, a nationwide review meeting was conducted on organ transplants in government hospitals by a group of top government experts to identify bottlenecks in the system and formulate a roadmap for improvement. The report underlined that government institutions have inadequate capacities and that new centres are required to be established and made functional. It emphasized the need for a multi-pronged strategy involving policy changes, financial investment, and capacity building to bridge the demand-supply gap in organ transplantation. Also Read | ₹1-crore health cover is fast becoming a necessity. But how to afford one? The report highlighted a huge gap between demand and supply: while India requires at least 100,000 kidney transplants per year, only 13,476 were performed in 2024 across both government and private centers. 'These recommendations aim to strengthen India's organ transplantation capabilities and make life-saving procedures more accessible to those in need. During the nationwide assessment of the government hospitals, we identified their challenges and suggested measures to improve their capabilities in terms of infrastructure, finance, manpower etc. We have submitted our report to the health ministry and now the ministry will take action on these recommendations," said Dr. Anil Kumar, director, NOTTO. One of the key recommendations is to include comprehensive inclusion of liver and heart transplantation in national health schemes like PMJAY, he added. 'Some states like Maharashtra and Delhi have expanded their coverage under the PM-JAY scheme. So, the recommendation of the report to include liver and heart transplantation under PM-JAY may be considered to accelerate organ transplantation in the government institutions," he said. Dr Anup Kumar, head of kidney transplant and urology department at Safdarjung Hospital, New Delhi, said, ' It is a welcome move. PMJAY offers coverage of up to ₹5 lakh, but these are very expensive procedures require ₹20-25 lakh in the private sector. However, in government institutions these transplants can be done in ₹10 lakh. So, to cover these two transplants, the government has to also consider increasing the coverage plan of PMJAY from ₹5 lakh to at least ₹10 lakh." Further, to bridge the critical demand-supply gap, the expert group has put forth several key recommendations, which include financial incentives for transplant teams, enhanced funding for infrastructure development, establishment of dedicated transplant centres and robust training programmes for medical personnel and transplant coordinators. 'We have tried to understand why government institutions are not able to do the maximum number of organ transplants and what are the solutions. Do we require to build new centres or strengthen the existing capacities. Some government centres like Institute of Kidney Diseases and Research Centre (IKDRC) Ahmedabad conducted a total of 508 organ transplants in the last year, including 195 cadaveric transplants, PGIMER Chandigarh performed 320 organ transplants including 55 cadaveric transplants," Dr. Kumar said. However, the report revealed that government institutions like GB Pant Hospital, New Delhi, despite having the physical infrastructure and licence, did not perform any organ transplants.
Mint
19 hours ago
- Mint
Drug regulator pushes for Braille labelling on medicines
New Delhi: India's top drug regulator is evaluating a plan for Braille labelling on medicine packaging to improve accessibility for India's 4.95 million blind and 70 million visually impaired citizens, who struggle to identify crucial medication details, said an official aware of the matter and documents reviewed by Mint. The Drugs Controller General of India (DCGI) is considering these changes based on a report of a subcommittee that recommended introducing Braille labelling for drugs packaged in mono cartons and for those frequently used by the visually impaired, such as eye drops. 'Currently, there is no labelling provision in the Drugs and Cosmetics Act and Rules that considers the needs of blind or visually impaired people," the panel recommended. 'As a result, this special category of people finds it difficult to know the name and expiry date of medicines. Therefore, a provision should be made to label drugs with Braille inscriptions." The recommendations stem from a 2020 representation highlighting the difficulties visually-impaired individuals faced when trying to read medicine strips. The subcommittee was first constituted in 2020 and then reconstituted in October 2024 under KR Chawal, Drug Controller and Licensing Authority of Delhi, along with three more members. Also read: Which private hospital is best for you? New grading system will help patients decide on treatment options An added benefit The committee report also said that Braille labelling will help combat counterfeit drugs. 'Braille fonts on drug pack labels are unique and difficult to copy, which could significantly reduce the incidence of drug duplication and spurious products in the market," according to the documents of the 66th Drugs Consultative Meeting (DCC) reviewed by Mint. India's spurious or counterfeit medicine drug sales are valued at $3 billion. The country's overall medicine market is currently valued at $50 billion, with domestic consumption at $23.5 billion, according to the department of pharmaceuticals. Queries emailed to the spokespersons of the health and family ministry and the DCGI remained unanswered till press time. Voluntary rollout, initially The subcommittee's recommendations presented to the Drugs Consultative Committee (DCC) on 17 June are currently under consideration to make the implementation voluntary or mandatory to start with through legislative amendments to the Drug Rules, 1945," said the official aware of the matter, requesting anonymity. "Initially, it has been proposed on a voluntary basis because people (drug makers) would take time to switch over to Braille labelling. We also have to see how the Indian industry is going to adapt to change. That is why it is being proposed for additional labelling in Braille language to be implemented 'initially on a voluntary basis' for drugs supplied in mono carton pack sizes," the official said. To ensure the accuracy of Braille labels, the subcommittee's report has recommended that drug manufacturers have their Braille artwork validated by nodal agencies such as the National Institute for the Empowerment of Persons with Intellectual Disabilities (NIEPID) through the Braille Council of India (BCI) or other NIEPID-recommended bodies. Also read: Centre moves to enhance organ transplant services in govt hospitals after review shows capacity constraints The report has excluded Braille labelling for medicines and other pharmaceutical items dispensed under direct healthcare professional supervision, including injectables and vaccines. Also, the report recommends that the competent authority issue an advisory to retailers, instructing them to verbally guide visually impaired customers about medicine names, dosage, indications, uses, and expiry dates. This guidance would be routinely monitored by enforcement officers. 'Putting Braille labelling on drug making is a good idea. Even if a 1% population gets benefits, it's worth doing, especially for life-saving drugs which are of significant use, and not just limiting it to certain eye drops," said Dr. J.S. Titiyal, head of Dr. Aggarwal's Eye Institute in New Delhi and former chief of RP Eye Centre at the All India Institute of Medical Sciences. He said that visually impaired individuals may have other health complications beyond eye issues. Dr. Manipal S. Sachdeva, chairman and managing director at Centre for Sight, said Braille labelling should be on all kinds of important life-saving medicines, not just eye drops. But he expressed reservations about making it a voluntary requirement. 'We don't know how the voluntary initiative will be picked up by the manufacturers, because it will add to their expense and logistic issues." Also read: Centre orders thorough safety review of painkiller Nimesulide for adults
Hindustan Times
a day ago
- Hindustan Times
Curbing phone addiction: Desi, physical games to challenge e-game fixation at UP govt primary schools
The Uttar Pradesh basic education department has introduced a calendar of traditional Indian games for students of Classes 1 to 8 across government primary and upper primary schools. The move is aimed at reconnecting children with their cultural roots and curbing the growing mobile phone addiction. The initiative, aligned with the National Education Policy (NEP) 2020, aims to encourage physical activity and reduce children's screen time by promoting indigenous games like Posham Pa and Langdi Taang. The calendar, prepared by experts from the State Institute of Education (SIE), Prayagraj—a unit of the State Council of Educational Research and Training (SCERT)—has been distributed digitally to around 1.5 lakh schools across the state, for the benefit of over 1.5 crore students. 'The illustrated PDF calendar has been shared with school principals, who have been instructed to incorporate these games into teacher-parent meetings and other school events to actively engage children,' said Anil Kumar, principal in-charge, SIE-Prayagraj. This initiative is a step toward reviving traditional games and improving both mental and physical health among students, he added. Officials hope the games will not only promote fitness and teamwork but also instill cultural pride among young learners.
